Severe acute interstitial pneumonia and gefitinib.
作者： Akira Inoue , Yasuo Saijo , Makoto Maemondo , Kazunori Gomi , Yutaka Tokue
DOI: 10.1016/S0140-6736(03)12190-3
关键词: Gefitinib 、 Diffuse alveolar damage 、 Respiratory disease 、 Carcinoma 、 Epidermal growth factor 、 Toxicity 、 Pathology 、 Acute Interstitial Pneumonia 、 Chemotherapy 、 Medicine
摘要: … Of interest, patient 10 had been given gefitinib for 83 days in a clinical trial with no serious … before restarting gefitinib in our institute. 2 weeks after the patient restarted gefitinib, however, …
elsevier.com
sci-hub.se 参考文章(2)
K. Takeyama, K. Dabbagh, H.-M. Lee, C. Agusti, J. A. Lausier, I. F. Ueki, K. M. Grattan, J. A. Nadel, Epidermal growth factor system regulates mucin production in airways Proceedings of the National Academy of Sciences of the United States of America. ,vol. 96, pp. 3081- 3086 ,(1999) , 10.1073/PNAS.96.6.3081
M Fukuoka, Final results from a phase II trial of ZD1839 ("Iressa") for patients with advanced non-small-cell lung cancer (IDEAL 1) Proc Am Soc Clin Oncol. ,vol. 21, ,(2002)